Weller M - Search Results

1

Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma.

Berghoff AS, Kiesel B, Widhalm G, Rajky O, Ricken G, Wöhrer A, Dieckmann K, Filipits M, Brandstetter A, Weller M, Kurscheid S, Hegi ME, Zielinski CC, Marosi C, Hainfellner JA, Preusser M, Wick W. Berghoff AS, et al. Among authors: weller m. Neuro Oncol. 2015 Aug;17(8):1064-75. doi: 10.1093/neuonc/nou307. Epub 2014 Oct 29. Neuro Oncol. 2015. PMID: 25355681 Free PMC article.

2

BCL-2 promotes migration and invasiveness of human glioma cells.

Wick W, Wagner S, Kerkau S, Dichgans J, Tonn JC, Weller M. Wick W, et al. Among authors: weller m. FEBS Lett. 1998 Dec 4;440(3):419-24. doi: 10.1016/s0014-5793(98)01494-x. FEBS Lett. 1998. PMID: 9872414 Free article.

3

Transforming growth factor-beta and p-21: multiple molecular targets of decorin-mediated suppression of neoplastic growth.

Ständer M, Naumann U, Wick W, Weller M. Ständer M, et al. Among authors: weller m. Cell Tissue Res. 1999 May;296(2):221-7. doi: 10.1007/s004410051283. Cell Tissue Res. 1999. PMID: 10382266 Review.

4

PTEN gene transfer in human malignant glioma: sensitization to irradiation and CD95L-induced apoptosis.

Wick W, Furnari FB, Naumann U, Cavenee WK, Weller M. Wick W, et al. Among authors: weller m. Oncogene. 1999 Jul 8;18(27):3936-43. doi: 10.1038/sj.onc.1202774. Oncogene. 1999. PMID: 10435616

5

Characterization of Tu-2449, a glioma cell line derived from a spontaneous tumor in GFAP-v-src-transgenic mice: comparison with established murine glioma cell lines.

Pohl U, Wick W, Weissenberger J, Steinbach JP, Dichgans J, Aguzzi A, Weller M. Pohl U, et al. Among authors: weller m. Int J Oncol. 1999 Oct;15(4):829-34. doi: 10.3892/ijo.15.4.829. Int J Oncol. 1999. PMID: 10493969

6

Malignant glioma biology: role for TGF-beta in growth, motility, angiogenesis, and immune escape.

Platten M, Wick W, Weller M. Platten M, et al. Among authors: weller m. Microsc Res Tech. 2001 Feb 15;52(4):401-10. doi: 10.1002/1097-0029(20010215)52:4<401::AID-JEMT1025>3.0.CO;2-C. Microsc Res Tech. 2001. PMID: 11170299 Review.

7

Preirradiation gemcitabine chemotherapy for newly diagnosed glioblastoma. A phase II study.

Weller M, Streffer J, Wick W, Kortmann RD, Heiss E, Küker W, Meyermann R, Dichgans J, Bamberg M. Weller M, et al. Cancer. 2001 Jan 15;91(2):423-7. doi: 10.1002/1097-0142(20010115)91:2<423::aid-cncr1017>3.0.co;2-h. Cancer. 2001. PMID: 11180090 Clinical Trial.

8

Treosulfan chemotherapy for recurrent malignant glioma.

Schmidt F, Wick W, Herrlinger U, Dichgans J, Weller M. Schmidt F, et al. Among authors: weller m. J Neurooncol. 2000 Sep;49(3):231-4. doi: 10.1023/a:1006496831144. J Neurooncol. 2000. PMID: 11212902 Clinical Trial.

9

Sublethal irradiation promotes migration and invasiveness of glioma cells: implications for radiotherapy of human glioblastoma.

Wild-Bode C, Weller M, Rimner A, Dichgans J, Wick W. Wild-Bode C, et al. Among authors: weller m. Cancer Res. 2001 Mar 15;61(6):2744-50. Cancer Res. 2001. PMID: 11289157

10

Molecular determinants of glioma cell migration and invasion.

Wild-Bode C, Weller M, Wick W. Wild-Bode C, et al. Among authors: weller m. J Neurosurg. 2001 Jun;94(6):978-84. doi: 10.3171/jns.2001.94.6.0978. J Neurosurg. 2001. PMID: 11409528

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,668 results

Search Page